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tions, recurrent upper and lower respiratory tract infections, and
neutropenia. The younger sister had repeated oral infections that
ultimately resulted in development of oral strictures. A twin sister
of the younger child who had a similar presentation died at age 3
years from a septic event.
Objective: To characterize the functional responses of patient neu-
trophils as a way to identify the underlying immunodeficiency.
Methods and Results: Neutrophils from both sisters exhibited nor-
mal O2- production to phorbol myristate, fMLF, and cytochalasin
B + zymosan. Although degranulation and staphylocidal activity
were not dramatically altered, a profound chemotactic defect
in vitro was detected. Microscopic examination of purified neu-
trophils from both sisters showed abnormal nuclear morphology in
40-50% of the cells with herniation of nuclear lobes into plasma
membrane-enclosed surface blebs. No abnormal morphology was
observed in the neutrophils on routine peripheral blood smears.
Electron microscopic examination of isolated cells confirmed ab-
normal morphology in both neutrophils and eosinophils. Moreover,
herniation of nuclear lobes coincided with retraction of the gran-
ules into the central region of the cells, resulting in an agranu-
lar region in the periphery of the cell. Confocal microscopy, using
Alexa Fluor 546-phalloidin to identify filamentous actin and DAPI
to localize nuclei, showed that cells with herniated nuclear lobes
exhibited increased levels of filamentous actin compared to either
patient cells with normal nuclear lobes or to normal neutrophils.
Conclusion: Abnormal nuclear morphology, profound chemotactic
defect, and cytoskeletal anomaly in these two sisters with recur-
rent infections represents a novel defect of neutrophils that is
likely autosomal recessive.
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Background: Primary immunodeficiencies characterized by selec-
tive predisposition to non-tuberculous mycobacteria (NTM) disease
include autosomal dominant and recessive disorders of the IL-
12/IL-23/IFN-γ axis including STAT1, and X-linked recessive defects
in NFκB-essential modulator (NEMO). In the process of evaluating
patients with disseminated NTM infections, we encountered a dis-
crete group of patients whose clinical course, laboratory features,
and family histories indicate a novel immunodeficiency.
Materials/Methods: We identified patients with severe NTM in-
fection, for whom mutations in the genes of the IL-12/IL-23/IFN-
gamma axis were excluded by function or sequence or both. We
also reviewed the medical charts of relevant family members.
Results: 14 patients were evaluated at the NIH and 9 affected fam-
ily members were identified (table). HIV was negative. This novel
syndrome is vertically transmitted, suggesting autosomal domi-
nance. The syndrome was identified by susceptibility to NTM in-
fections. It is characterized by profound circulating monocytope-
nia, and B and NK lymphocytopenia. HPV infection was common
(n=13) and severe with several cases of progression to neoplasia;
individual cases had severe EBV or VZV. Invasive fungal infections
occurred primarily with moulds (4 with Aspergillus spp. or its teleo-
morph, Neosartorya spp.), although 1 case involved C .neoformans
and 2 patients had disseminated histoplasmosis. Four patients de-
veloped pulmonary alveolar proteinosis (PAP), a disorder of exces-
sive lipoproteinaceous material within alveoli, but they did not
have mutations in the GM-CSF receptor or detectable autoantibod-
ies to GM-CSF. Nine cases progressed to myelodysplastic syndrome
or leukemia, 1 developed aplastic anemia, and 5 developed clonal
proliferation of large granular lymphocytes. Of the 23 cases, 11
(47.8%) are deceased.
Conclusions: This novel autosomal dominant immunodeficiency
syndrome is characterized by profound circulating monocytope-
nia and adult-onset mycobacterial disease. Infectious susceptibil-
ity extends to viruses, especially HPV, and to moulds. Development
of PAP, progression to myelodysplasia, and high mortality suggest
early definitive intervention such as bone marrow transplantation
is warranted.
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Background: Idiopathic CD4 lymphocytopenia (ICL) is a rare non-
HIV related syndrome first defined in 1992 as an absolute CD4 T
lymphocyte count of less than 300 cells/mm3 or of less than 20%
of total T cells on more than one occasion and the absence of any
defined immunodeficiency or therapy associated with low CD4 T
cells. It is a rare, heterogenous syndrome not caused by HIV-1 or 2,
HTLV-I or II or other transmissible agent.
Objectives: The clinical course, immunologic characteristics, CD4
T cell kinetics, long-term outcome and prognosis of this syndrome
have not been studied adequately.
Materials and Methods: Patients with ICL were enrolled between
1992 and 2006 in a NIH coordinated prospective natural history
clinical study. This included clinical assessment, history, immuno-
logic and virologic investigation while the patients were followed
at least annually.
Results: Thirty-nine patients (17 men, 22 women), 25 to 85 years
old with ICL were evaluated and thirty-six were followed for a
median of 49.5 months (range). Most of the patients presented
with cryptococcal and non-tuberculous mycobacterial infections,
while seven patients presented with no infection (incidental find-
ing of low CD4 T cell count). In thirty-two, CD4 T cell counts re-
mained below 300/mm3 during the entire study period without
progression of lymphopenia and in seven normalized after an av-
erage of 31 months. Using a linear mixed model approach to fit
the individual CD4 trajectories, the CD4 velocity was estimated at
0.66/mm3/month (95% CI: -0.20, 1.54) and was not significantly
different from zero (p=0.13). Overall, fifteen patients (41.6%) de-
veloped an opportunistic infection in follow up (mostly HPV, VZV in-
fections and candidiasis), five (13.8%) of which were AIDS defining
clinical conditions, and four patients (11.1%) developed autoim-
mune diseases. Patients without opportunistic infections (OIs) at
presentation remained asymptomatic. Seven patients died, four
from ICL related opportunistic infections within 42 months of di-
agnosis. CD8 T lymphocytopenia (<180/mm3) and high CD4 T cell
activation (measured by HLA-DR expression) at presentation were
associated with adverse outcome (ICL related death) (p=0.003 and
0.02 respectively).
Conclusions: ICL is a heterogeneous yet distinctive, clinically and
immunologically, from HIV infection condition. CD4 T cell counts
in ICL remain stable or improve in the majority of patients but
life-threatening OIs and autoimmune diseases can occur.
